BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report dated July 24, 2023 on Postal Ballot24-07-2023
24-07-2023
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Voting Results on Postal Ballot24-07-2023
Biocon shares fall 2% after Malaysia unit receives 6 observations from USFDA
The company to announce results for the quarter ended June on August 10, 2023.24-07-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release24-07-2023
BIOCON LTD. - 532523 - Company Statement
Company Statement w.r.t. ''U.S. FDA Completes Two cGMP Inspections at Biocon Biologics'' Insulins Facility in Malaysia''21-07-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper Advertisement published on July 21, 2023 in Financial Express (English Language) and Vijayavani (Kannada Language) regarding Notice of 45th Annual General Meeting etc.21-07-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference Call for analysts/investors on Friday, August 11, 202321-07-2023
BIOCON LTD. - 532523 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended June 30, 2023
BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 202321-07-2023
BIOCON LTD. - 532523 - Business Responsibility and Sustainability Reporting (BRSR)
BRSR, GRI & ESG Data Book for the FY 2022-2320-07-2023
BIOCON LTD. - 532523 - Reg. 34 (1) Annual Report.
Annual Report (BRSR, GRI & ESG Data Book is a supplement to the Annual Report) for the FY 2022-2320-07-2023